6-160731262-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000301.5(PLG):​c.1438+30A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 1,567,980 control chromosomes in the GnomAD database, including 55,153 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.21 ( 4000 hom., cov: 32)
Exomes 𝑓: 0.26 ( 51153 hom. )

Consequence

PLG
NM_000301.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.822

Publications

14 publications found
Variant links:
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Gene-Disease associations (from GenCC):
  • hypoplasminogenemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • angioedema, hereditary, 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-160731262-A-G is Benign according to our data. Variant chr6-160731262-A-G is described in ClinVar as Benign. ClinVar VariationId is 1245480.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLGNM_000301.5 linkc.1438+30A>G intron_variant Intron 11 of 18 ENST00000308192.14 NP_000292.1 P00747

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLGENST00000308192.14 linkc.1438+30A>G intron_variant Intron 11 of 18 1 NM_000301.5 ENSP00000308938.9 P00747

Frequencies

GnomAD3 genomes
AF:
0.211
AC:
32130
AN:
152076
Hom.:
4004
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.223
Gnomad AMR
AF:
0.196
Gnomad ASJ
AF:
0.305
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.102
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.290
Gnomad OTH
AF:
0.228
GnomAD2 exomes
AF:
0.209
AC:
52344
AN:
250586
AF XY:
0.213
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.122
Gnomad ASJ exome
AF:
0.291
Gnomad EAS exome
AF:
0.000708
Gnomad FIN exome
AF:
0.259
Gnomad NFE exome
AF:
0.295
Gnomad OTH exome
AF:
0.232
GnomAD4 exome
AF:
0.258
AC:
364745
AN:
1415786
Hom.:
51153
Cov.:
24
AF XY:
0.255
AC XY:
180216
AN XY:
707122
show subpopulations
African (AFR)
AF:
0.0961
AC:
3127
AN:
32526
American (AMR)
AF:
0.128
AC:
5713
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
0.290
AC:
7510
AN:
25864
East Asian (EAS)
AF:
0.000531
AC:
21
AN:
39522
South Asian (SAS)
AF:
0.107
AC:
9149
AN:
85460
European-Finnish (FIN)
AF:
0.262
AC:
13975
AN:
53302
Middle Eastern (MID)
AF:
0.254
AC:
1421
AN:
5600
European-Non Finnish (NFE)
AF:
0.289
AC:
309636
AN:
1070012
Other (OTH)
AF:
0.241
AC:
14193
AN:
58856
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
11300
22601
33901
45202
56502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9678
19356
29034
38712
48390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.211
AC:
32122
AN:
152194
Hom.:
4000
Cov.:
32
AF XY:
0.207
AC XY:
15390
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.104
AC:
4319
AN:
41534
American (AMR)
AF:
0.196
AC:
2990
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.305
AC:
1059
AN:
3468
East Asian (EAS)
AF:
0.00174
AC:
9
AN:
5178
South Asian (SAS)
AF:
0.102
AC:
492
AN:
4824
European-Finnish (FIN)
AF:
0.262
AC:
2776
AN:
10604
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.290
AC:
19735
AN:
67982
Other (OTH)
AF:
0.225
AC:
475
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1303
2606
3909
5212
6515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.266
Hom.:
7842
Bravo
AF:
0.204
Asia WGS
AF:
0.0460
AC:
164
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.27
DANN
Benign
0.34
PhyloP100
-0.82
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4252126; hg19: chr6-161152294; COSMIC: COSV51983676; COSMIC: COSV51983676; API